Wednesday, August 9, 2023 Daily Archives

AGC completes Italy CGT plant expansion

AGC Biologics said the completed expansion of its cell and gene therapy site in Milan, Italy will support industry demand. Contract development manufacturing organization (CDMO) AGC launched a voluntary tender offer to acquire Italian cell and gene therapy (CGT) developer and manufacturer MolMed for €240 million ($284 million). In July 2020, the deal closed. The CDMO has now completed a 2,500m2 expansion at its Milan site for adeno-associated and lentiviral vector development and production has been built to accommodate large-scale…

UK consortium awarded $1m to develop iPSC platform

UK Innovate Biomedical Catalyst has awarded Plasticell, CGT Catapult and Imperial College London with £800,000 ($1m) to develop an integrated allogeneic iPSC platform. The two-year project will be led by Plasticell, a firm focused on developing stem cell technologies and advanced therapies. Additionally, the team includes the Cell and Gene Therapy Catapult (CGT Catapult) an organization aiming to advance cell and gene therapies, and Imperial College London. “This project is a valuable opportunity to develop an efficient and scalable way…